REGENXBIO Company Information

REGENXBIO Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: REGENXBIO Inc.
  • Ticker: RGNX
  • Exchange: NasdaqGS
  • Founded: 2008
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$1.143b
  • Shares outstanding: 43.23m
  • Website: https://www.regenxbio.com

Number of Employees


Location

  • REGENXBIO Inc.
  • 9804 Medical Center Drive
  • Rockville
  • Maryland
  • 20850
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RGNXNasdaqGS (Nasdaq Global Select)YesCommon SharesUSUSDSep 2015
RB0DB (Deutsche Boerse AG)YesCommon SharesDEEURSep 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/30 00:00
End of Day Share Price2022/09/30 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.